Evaluation of Lytic Bacteriophages for Control of Multidrug-resistant Salmonella Typhimurium

Overview

Journal Ann Clin Microbiol Antimicrob

Publisher Biomed Central

Specialties Infectious Diseases
Microbiology

Date 2017 Sep 24

PMID 28938899

Citations 19

Authors

Lae-Seung Jung

Tian Ding

Juhee Ahn

Affiliations

Soon will be listed here.

Abstract

Background: The emergence of antibiotic-resistant bacteria can cause serious clinical and public health problems. This study describes the possibility of using bacteriophages as an alternative agent to control multidrug-resistant Salmonella Typhimurium.

Methods: The potential lytic bacteriophages (P22-B1, P22, PBST10, PBST13, PBST32, and PBST 35) were characterized by morphological property, heat and pH stability, optimum multiplicity of infection (MOI), and lytic activity against S. Typhimurium KCCM 40253, S. Typhimurium ATCC 19585, ciprofloxacin-induced antibiotic-resistant S. Typhimurium ATCC 19585, and S. Typhimurium CCARM 8009.

Results: P22-B1 and P22 belong to Podoviridae family and PBST10, PBST13, PBST32, and PBST 35 show a typical structure with polyhedral head and long tail, belonging to Siphoviridae family. Salmonella bacteriophages were highly stable at the temperatures (< 60 °C) and pHs (5.0-11.0). The reduction rates of host cells were increased at the MOI-dependent manner, showing the highest reduction rate at MOI of 10. The host cells were most effectively reduced by P22, while P22-B1 showed the least lytic activity. The ciprofloxacin-induced antibiotic-resistant S. Typhimurium ATCC 19585, and clinically isolated antibiotic-resistant S. Typhimurium CCARM 8009 were resistant to ciprofloxacin, levofloxacin, norfloxacin, and tetracycline. P22 showed the highest lytic activity against S. Typhimurium KCCM 40253 (> 5 log reduction), followed by S. Typhimurium ATCC 19585 (4 log reduction) and ciprofloxacin-induced antibiotic-resistant S. Typhimurium ATCC 19585 (4 log reduction).

Conclusion: The results would provide vital insights into the application of lytic bacteriophages as an alternative therapeutics for the control of multidrug-resistant pathogens.

Citing Articles

Advancements in Detection Methods for in Food: A Comprehensive Review.

Patel A, Wolfram A, Desin T Pathogens. 2025; 13(12.

PMID: 39770335 PMC: 11728791. DOI: 10.3390/pathogens13121075.

A novel lytic phage infecting MDR and its application as effective food biocontrol.

Jaglan A, Verma R, Vashisth M, Virmani N, Bera B, Vaid R Front Microbiol. 2024; 15:1387830.

PMID: 39211316 PMC: 11358711. DOI: 10.3389/fmicb.2024.1387830.

Mini review advantages and limitations of lytic phages compared with chemical antibiotics to combat bacterial infections.

Guo Z, Yuan M, Chai J Heliyon. 2024; 10(14):e34849.

PMID: 39148970 PMC: 11324966. DOI: 10.1016/j.heliyon.2024.e34849.

Identification of a lytic bacteriophage against clinical isolates of in turkey poults.

Amini M, Ownagh A, Tukmechi A, Allymehr M Vet Res Forum. 2024; 15(6):309-316.

PMID: 39035474 PMC: 11260226. DOI: 10.30466/vrf.2023.2000885.3864.

Bacteriophages: The promising therapeutic approach for enhancing ciprofloxacin efficacy against bacterial infection.

Shariati A, Noei M, Chegini Z J Clin Lab Anal. 2023; 37(9-10):e24932.

PMID: 37377167 PMC: 10388223. DOI: 10.1002/jcla.24932.

References

Bielke L, Higgins S, Donoghue A, Donoghue D, Hargis B . Salmonella host range of bacteriophages that infect multiple genera. Poult Sci. 2007; 86(12):2536-40. DOI: 10.3382/ps.2007-00250. View

Lu Y, Zhao H, Sun J, Liu Y, Zhou X, Beier R . Characterization of multidrug-resistant Salmonella enterica serovars Indiana and Enteritidis from chickens in Eastern China. PLoS One. 2014; 9(5):e96050. PMC: 4008530. DOI: 10.1371/journal.pone.0096050. View

Chow M, Rouf M . Isolation and Partial Characterization of Two Aeromonas hydrophila Bacteriophages. Appl Environ Microbiol. 1983; 45(5):1670-6. PMC: 242514. DOI: 10.1128/aem.45.5.1670-1676.1983. View

Fischetti V . Bacteriophage lysins as effective antibacterials. Curr Opin Microbiol. 2008; 11(5):393-400. PMC: 2597892. DOI: 10.1016/j.mib.2008.09.012. View

Beceiro A, Tomas M, Bou G . Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?. Clin Microbiol Rev. 2013; 26(2):185-230. PMC: 3623377. DOI: 10.1128/CMR.00059-12. View

Woo J, Ahn J . Assessment of synergistic combination potential of probiotic and bacteriophage against antibiotic-resistant Staphylococcus aureus exposed to simulated intestinal conditions. Arch Microbiol. 2014; 196(10):719-27. DOI: 10.1007/s00203-014-1013-z. View

Javed M, Poshtiban S, Arutyunov D, Evoy S, Szymanski C . Bacteriophage receptor binding protein based assays for the simultaneous detection of Campylobacter jejuni and Campylobacter coli. PLoS One. 2013; 8(7):e69770. PMC: 3715477. DOI: 10.1371/journal.pone.0069770. View

Kahr A, Pechere J . In vitro stepwise selection of resistance to quinolones, beta-lactams and amikacin in nosocomial gram-negative bacilli. Infection. 1994; 22 Suppl 2:S105-10. DOI: 10.1007/BF01793574. View

Jassim S, Limoges R . Natural solution to antibiotic resistance: bacteriophages 'The Living Drugs'. World J Microbiol Biotechnol. 2014; 30(8):2153-70. PMC: 4072922. DOI: 10.1007/s11274-014-1655-7. View

10.

Muller-Merbach M, Kohler K, Hinrichs J . Environmental factors for phage-induced fermentation problems: replication and adsorption of the Lactococcus lactis phage P008 as influenced by temperature and pH. Food Microbiol. 2007; 24(7-8):695-702. DOI: 10.1016/j.fm.2007.04.003. View

11.

Tenover F . Mechanisms of antimicrobial resistance in bacteria. Am J Med. 2006; 119(6 Suppl 1):S3-10. DOI: 10.1016/j.amjmed.2006.03.011. View

12.

Mulvey M, Finley R, Allen V, Ang L, Bekal S, El Bailey S . Emergence of multidrug-resistant Salmonella enterica serotype 4,[5],12:i:- involving human cases in Canada: results from the Canadian Integrated Program on Antimicrobial Resistance Surveillance (CIPARS), 2003-10. J Antimicrob Chemother. 2013; 68(9):1982-6. DOI: 10.1093/jac/dkt149. View

13.

Kim J, Jo A, Ding T, Lee H, Ahn J . Assessment of altered binding specificity of bacteriophage for ciprofloxacin-induced antibiotic-resistant Salmonella Typhimurium. Arch Microbiol. 2016; 198(6):521-9. DOI: 10.1007/s00203-016-1210-z. View

14.

Giraud E, Cloeckaert A, Kerboeuf D, Chaslus-Dancla E . Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar typhimurium. Antimicrob Agents Chemother. 2000; 44(5):1223-8. PMC: 89848. DOI: 10.1128/AAC.44.5.1223-1228.2000. View

15.

Rakhuba D, Kolomiets E, Szwajcer Dey E, Novik G . Bacteriophage receptors, mechanisms of phage adsorption and penetration into host cell. Pol J Microbiol. 2010; 59(3):145-55. View

16.

Wong C, Sieo C, Tan W, Abdullah N, Hair-Bejo M, Abu J . Evaluation of a lytic bacteriophage, Φ st1, for biocontrol of Salmonella enterica serovar Typhimurium in chickens. Int J Food Microbiol. 2013; 172:92-101. DOI: 10.1016/j.ijfoodmicro.2013.11.034. View

17.

Matsuzaki S, Rashel M, Uchiyama J, Sakurai S, Ujihara T, Kuroda M . Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases. J Infect Chemother. 2005; 11(5):211-9. DOI: 10.1007/s10156-005-0408-9. View

18.

Qimron U, Marintcheva B, Tabor S, Richardson C . Genomewide screens for Escherichia coli genes affecting growth of T7 bacteriophage. Proc Natl Acad Sci U S A. 2006; 103(50):19039-44. PMC: 1748173. DOI: 10.1073/pnas.0609428103. View

19.

Dionisi A, Lucarelli C, Benedetti I, Owczarek S, Luzzi I . Molecular characterisation of multidrug-resistant Salmonella enterica serotype Infantis from humans, animals and the environment in Italy. Int J Antimicrob Agents. 2011; 38(5):384-9. DOI: 10.1016/j.ijantimicag.2011.07.001. View

20.

Khameneh B, Diab R, Ghazvini K, Bazzaz B . Breakthroughs in bacterial resistance mechanisms and the potential ways to combat them. Microb Pathog. 2016; 95:32-42. DOI: 10.1016/j.micpath.2016.02.009. View